BioVoice eMagazine March 2025 | Issue 3 | Volume 6

The Cover Story tracks the surge in the big-ticket investments by MNCs to spearhead the next wave of innovation. Read interview of Shailendra Vyas CEO and Director, Bioheaven360 Genotec. Expert Insights by Shereef Rehuman, MD, ICEXPO Consults and Daara Patel, Secretary General, IDMA; and Ninad Karandikar, Co-founder, Stance Health

0
120
Click to Read: March 2025 Edition of BioVoice eMagazine

♦ COVER STORY
A SURGE IN BIG TICKET INVESTMENTS
MNCs Powering the Next Wave of Innovation
We take a deep dive into the capital flows behind bioscience industry’s resurgence, especially biotechnology and medical technology industries. Last two years have witnessed a growing interest in the artificial intelligence driven drug development for precision medicine and next-gen biologics. Similarly, the setting of R&D centres and manufacturing facilities within the medical technology sector reinforce a growing belief in the India story globally.

♦ INTERVIEW
Our research specifically focuses on understanding how gene function changes with age
 In an exclusive interview, Shailendra Vyas CEO and Director, Bioheaven360 Genotec shares details on the company’s journey so far, its key offerings, upcoming initiatives, and future plans.

EXPERT INSIGHTS
Pharma and Digital Health: Creating Synergies through B2B Collaboration for Better Outcomes
In this jointly authored opinion article, Shereef Rehuman, MD, ICEXPO Consults and Daara Patel, Secretary General, IDMA explain the growing relevance of digital health for pharmaceuticals.

♦ EXPERT INSIGHTS
The Future of MSK Care: AI-Powered Diagnosis and Personalized Treatment
Ninad Karandikar, Co-founder of Stance Health shares his views on the role of latest digital technologies in treating the musculoskeletal disorders.

Click to Read: March 2025 Edition of BioVoice eMagazine